These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 20146822
21. The OspE-related proteins inhibit complement deposition and enhance serum resistance of Borrelia burgdorferi, the lyme disease spirochete. Kenedy MR, Akins DR. Infect Immun; 2011 Apr; 79(4):1451-7. PubMed ID: 21282413 [Abstract] [Full Text] [Related]
22. New Insights Into CRASP-Mediated Complement Evasion in the Lyme Disease Enzootic Cycle. Lin YP, Frye AM, Nowak TA, Kraiczy P. Front Cell Infect Microbiol; 2020 Apr; 10():1. PubMed ID: 32083019 [Abstract] [Full Text] [Related]
30. Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype. Wilske B, Jauris-Heipke S, Lobentanzer R, Pradel I, Preac-Mursic V, Rössler D, Soutschek E, Johnson RC. J Clin Microbiol; 1995 Jan; 33(1):103-9. PubMed ID: 7699024 [Abstract] [Full Text] [Related]
33. Evaluation of a genotyping method based on the ospA gene to detect Borrelia burgdorferi sensu lato in multiple samples of lyme borreliosis patients. Floris R, Menardi G, Bressan R, Trevisan G, Ortenzio S, Rorai E, Cinco M. New Microbiol; 2007 Oct; 30(4):399-410. PubMed ID: 18080675 [Abstract] [Full Text] [Related]
34. Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi. Siegel C, Hallström T, Skerka C, Eberhardt H, Uzonyi B, Beckhaus T, Karas M, Wallich R, Stevenson B, Zipfel PF, Kraiczy P. PLoS One; 2010 Oct 20; 5(10):e13519. PubMed ID: 20975954 [Abstract] [Full Text] [Related]
36. CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi. Kenedy MR, Vuppala SR, Siegel C, Kraiczy P, Akins DR. Infect Immun; 2009 Jul 20; 77(7):2773-82. PubMed ID: 19451251 [Abstract] [Full Text] [Related]
37. Assignment of Borrelia burgdorferi strains G25 and VS461 to the Borrelia garinii and Borrelia afzelii genospecies, respectively: a comparison of OspA protein sequences. Godfroid E, Ben Messaoud A, Poliszczak A, Lobet Y, Bollen A. DNA Seq; 1995 Jul 20; 5(4):251-4. PubMed ID: 7626787 [Abstract] [Full Text] [Related]
38. CspA from Borrelia burgdorferi inhibits the terminal complement pathway. Hallström T, Siegel C, Mörgelin M, Kraiczy P, Skerka C, Zipfel PF. mBio; 2013 Aug 13; 4(4):. PubMed ID: 23943762 [Abstract] [Full Text] [Related]
39. Development and validation of a FACS-based lipoprotein localization screen in the Lyme disease spirochete Borrelia burgdorferi. Kumru OS, Schulze RJ, Slusser JG, Zückert WR. BMC Microbiol; 2010 Nov 03; 10():277. PubMed ID: 21047413 [Abstract] [Full Text] [Related]
40. [Prevalence of Borrelia burgdorferi sensu lato species among patients in the Czech Republic; direct sequencing analysis and real-time polymerase chain reaction]. Hulínská D, Drevová H, Votýpka J, Langrová K, Kurzová Z. Epidemiol Mikrobiol Imunol; 2004 Nov 03; 53(4):183-91. PubMed ID: 15633539 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]